• Je něco špatně v tomto záznamu ?

Quercetin attenuates the ischemia reperfusion induced COX-2 and MPO expression in the small intestine mucosa

Š. Tóth, Z. Jonecová, K. Čurgali, M. Maretta, J. Šoltés, M. Švaňa, T. Kalpadikis, M. Caprnda, M. Adamek, L. Rodrigo, P. Kruzliak,

. 2017 ; 95 (-) : 346-354. [pub] 20170912

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc18024695

Quercetin, the active substance of tea, fruits and vegetables, exerts a broad spectrum of pharmacological activities and is considered to have potential therapeutic application. The present study was designed to investigate the beneficial effect of quercetin against experimental ischemia- reperfusion (IR) injury of the small intestine in rats. Quercetin was administrated intraperitoneally 30min before 1h ischemia of superior mesenteric artery with following reperfusion periods lasting 1, 4 and 24h. The male specific pathogen-free Charles River Wistar rats were used (n=45). In acute phase, 4h after start of reperfusion, the quercetin induced a significant decrease in mucosal injury index (p<0.05) accompanied by a significant decrease in cyclooxygenase-2 (COX-2) expression in the epithelial lining of the intestinal villi in comparison with the control group (p<0.01). In the epithelium of the intestinal glands, COX-2 expression resulting from IR injury significantly increased regardless quercetin application (in control group p<0.001; in quercetin group p<0.05), but in quercetin group, significant decrease in it during 24h of reperfusion in a late phase of IR injury was detected (p<0.001). Based on morphology of COX-2 positive cells, the COX-2 positivity was found particularly in goblet cells of the intestinal villi epithelium and enteroendocrine cells respectively, in the glandular epithelium. We concluded that quercetin application attenuated mucosal damage from IR injury by inhibiting neutrophil infiltration which was demonstrated by a lower number of myeloperoxidase positive cells in the lamina propria during both phases of IR injury and the significant decrease in that in a late phase after 24h of reperfusion (p<0.05).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc18024695
003      
CZ-PrNML
005      
20220923093452.0
007      
ta
008      
180709s2017 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.biopha.2017.08.038 $2 doi
035    __
$a (PubMed)28858733
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Tóth, Štefan $u Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
245    10
$a Quercetin attenuates the ischemia reperfusion induced COX-2 and MPO expression in the small intestine mucosa / $c Š. Tóth, Z. Jonecová, K. Čurgali, M. Maretta, J. Šoltés, M. Švaňa, T. Kalpadikis, M. Caprnda, M. Adamek, L. Rodrigo, P. Kruzliak,
520    9_
$a Quercetin, the active substance of tea, fruits and vegetables, exerts a broad spectrum of pharmacological activities and is considered to have potential therapeutic application. The present study was designed to investigate the beneficial effect of quercetin against experimental ischemia- reperfusion (IR) injury of the small intestine in rats. Quercetin was administrated intraperitoneally 30min before 1h ischemia of superior mesenteric artery with following reperfusion periods lasting 1, 4 and 24h. The male specific pathogen-free Charles River Wistar rats were used (n=45). In acute phase, 4h after start of reperfusion, the quercetin induced a significant decrease in mucosal injury index (p<0.05) accompanied by a significant decrease in cyclooxygenase-2 (COX-2) expression in the epithelial lining of the intestinal villi in comparison with the control group (p<0.01). In the epithelium of the intestinal glands, COX-2 expression resulting from IR injury significantly increased regardless quercetin application (in control group p<0.001; in quercetin group p<0.05), but in quercetin group, significant decrease in it during 24h of reperfusion in a late phase of IR injury was detected (p<0.001). Based on morphology of COX-2 positive cells, the COX-2 positivity was found particularly in goblet cells of the intestinal villi epithelium and enteroendocrine cells respectively, in the glandular epithelium. We concluded that quercetin application attenuated mucosal damage from IR injury by inhibiting neutrophil infiltration which was demonstrated by a lower number of myeloperoxidase positive cells in the lamina propria during both phases of IR injury and the significant decrease in that in a late phase after 24h of reperfusion (p<0.05).
650    _2
$a zvířata $7 D000818
650    _2
$a cyklooxygenasa 2 $x biosyntéza $7 D051546
650    _2
$a enzymová indukce $7 D004790
650    _2
$a epitelové buňky $x účinky léků $x enzymologie $7 D004847
650    _2
$a střevní sliznice $x účinky léků $x enzymologie $x zranění $x patologie $7 D007413
650    _2
$a tenké střevo $x patologie $7 D007421
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a peroxidasa $x biosyntéza $7 D009195
650    _2
$a quercetin $x farmakologie $x terapeutické užití $7 D011794
650    _2
$a potkani Wistar $7 D017208
650    _2
$a reperfuzní poškození $x farmakoterapie $x enzymologie $7 D015427
655    _2
$a časopisecké články $7 D016428
700    1_
$a Jonecová, Zuzana $u Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
700    1_
$a Čurgali, Kristína $u Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
700    1_
$a Maretta, Milan $u Department of Neurology, Louis Pasteur University Hospital, Kosice, Slovakia.
700    1_
$a Šoltés, Ján $u Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia. $7 xx0276976
700    1_
$a Švaňa, Martin $u Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
700    1_
$a Kalpadikis, Theodore $u Department of Histology and Embryology, Faculty of Medicine, Pavol Jozef Safarik University, Kosice, Slovakia.
700    1_
$a Caprnda, Martin $u 1st Department of Internal Medicine, Faculty of Medicine, Comenius University and University Hospital, Bratislava, Slovakia.
700    1_
$a Adamek, Mariusz $u Department of Thoracic Surgery, Faculty of Medicine and Dentistry, Medical University of Silesia, Katowice, Poland.
700    1_
$a Rodrigo, Luis $u University of Oviedo, Central University Hospital of Asturias (HUCA), Oviedo, Spain.
700    1_
$a Kruzliak, Peter $u Department of Chemical Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences, Brno, Czech Republic. Electronic address: kruzliakpeter@gmail.com.
773    0_
$w MED00005486 $t Biomedicine & pharmacotherapy Biomedecine & pharmacotherapie $x 1950-6007 $g Roč. 95, č. - (2017), s. 346-354
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28858733 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20180709 $b ABA008
991    __
$a 20220923093445 $b ABA008
999    __
$a ok $b bmc $g 1316826 $s 1021616
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 95 $c - $d 346-354 $e 20170912 $i 1950-6007 $m Biomedicine & pharmacotherapy $n Biomed Pharmacother $x MED00005486
LZP    __
$a Pubmed-20180709

Najít záznam

Citační ukazatele

Možnosti archivace